Microscopic colitis: a missed diagnosis among patients with moderate to severe irritable bowel syndrome

Scandinavian Journal of Gastroenterology

Volumn 52, Issue 2, 2017, Pages 173-177

  Hilpüsch, Frank ^a   Johnsen, Peter Holger ^b,c   Goll, Rasmus ^b,c   Valle, Per Christian ^b   Sørbye, Sveinung Wergeland ^b   Abelsen, Birgit ^b,c  

^a Sjøkanten legesenter and Bjarkøy legekontor   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

differential diagnosis; general practise; Irritable bowel syndrome; microscopic colitis

Indexed keywords

CALGRANULIN;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; COLONOSCOPY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; FECES ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC COLITIS; MIDDLE AGED; PRIORITY JOURNAL; SYMPTOM; ULCERATIVE COLITIS; BIOPSY; COLITIS, MICROSCOPIC; DIARRHEA; GENERAL PRACTICE; IRRITABLE BOWEL SYNDROME; NORWAY; PATHOLOGY; YOUNG ADULT;

ADULT; AGED; BIOPSY; COLITIS, MICROSCOPIC; COLONOSCOPY; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; FEMALE; GENERAL PRACTICE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; NORWAY; YOUNG ADULT;

EID: 84992745906     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365521.2016.1242025     Document Type: Article

References (41)

1. Longstreth GF., Definition and classification of irritable bowel syndrome:current consensus and controversies. Gastroenterol Clin North Am. 2005;34:173–187.
2. Thompson WG, Creed FH, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gastroenterol Int. 1992;5:75–91.
3. Saito YA, Schoenfeld P, Locke GRI., The epidemiology of irritable bowel syndrome in North America:a systematic review. Am J Gastroenterol. 2002;97:1910–1915.
4. Oberndorff-Klein Woolthuis AH, Brummer RJ, de Wit NJ, et al. Irritable bowel syndrome in general practise:an overview. Scand J Gastroenterol. 2004;39:17–22.
5. Thompson WG, Heaton KW, Smyth GT, et al. Irritable bowel syndrome in general practice:prevalence, characteristics, and referral. Gut. 2000;46:78–82.
6. Manning AP, Thompson WD, Heaton KW, et al. Towards positive diagnosis of the irritable bowel. Br Med J. 1978;2:653–654.
7. Jeong H, Lee HR, Yoo BC, et al. Manning criteria in irritable bowel syndrome:its diagnostic significance. Korean J Intern Med. 1993;8:357–363.
8. Drossman DA, Dumitrascu DL., Rome III:new standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis. 2006;15:237–241.
9. Thompson WG., The road to Rome. Gut. 1999;45:1180–1181.
10. Dang J, Ardila-Hani A, Amichai MM, et al. Systematic review of diagnostic criteria for IBS demonstrates poor validity and utilization of Rome III. Neurogastroenterol Motil. 2012;24:853–860.
11. Kruis W, Thieme C, Weinzierl M, et al. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology. 1984;87:1–7.
12. Vanner SJ, Depew WT, Paterson WG, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol. 1999;94:2912–2917.
13. Sperber AD, Shvartzman P, Friger M, et al. A comparative reappraisal of the Rome II and Rome III diagnostic criteria:are we getting closer to the ‘true’ prevalence of irritable bowel syndrome? Eur J Gastroenterol Hepatol. 2007;19:441–447.
14. Whitehead WE, Drossman DA., Validation of symptom-based diagnostic criteria for irritable bowel syndrome:a critical review. Am J Gastroenterol. 2010;105:814–820.
15. Vandvik PO, Aabakken L, Farup PG., Diagnosing irritable bowel syndrome:poor agreement between general practitioners and the Rome II criteria. Scand J Gastroenterol. 2004;39:448–453.
16. Ford AC, Bercik P, Morgan DG, et al. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology. 2013;145:1262–1270.
17. Engsbro AL, Begtrup LM, Kjeldsen J, et al. Patients suspected of irritable bowel syndrome-cross-sectional study exploring the sensitivity of Rome III criteria in primary care. Am J Gastroenterol. 2013;108:972–980.
18. Spiller R, Aziz Q, Creed F, et al. Guidelines on the irritable bowel syndrome:mechanisms and practical management. Gut. 2007;56:1770–1798.
19. Brandt LJ, Chey WD, Foxx-Orenstein AE, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol. 2009;104:S1–S35.
20. Drossman DA, Camilleri M, Mayer EA, et al. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123:2108–2131.
21. Ford AC, Brennan M, Spiegel R, et al. Small intestinal bacterial overgrowth in irritable bowel syndrome. Systematic review and meta-analysis. Clin Gastroenterol Hep. 2009;7:1279–1286.
22. Lucak S., Diagnosing irritable bowel syndrome:what′s too much, what′s enough? MedGen Med. 2004;6:1.
23. Canavan C, West J, Card T., The epidemiology of irritable bowel syndrome. Clin Epidemiol. 2014;6:71–80.
24. Pardi DS., Microscopic colitis:an update. Inflamm Bowel Dis. 2004;10:860–870.
25. Read N, Krejs G, Read M, et al. Chronic diarrhea of unknown origin. Gastroenterology. 1980;78:264–271.
26. Lindstrøm CG., Collagenous colitis with watery diarrhoea:a new entity? Pathol Europ. 1976;11:87–89.
27. Lazenby A, Yardley J, Giardiello F, et al. Lymphocytic (microscopic) colitis:a comparative histopathologic study with particular reference to collagenous colitis. Hum Path. 1989;20:18–28.
28. Bohr J, Wickbom A, Hegedus A, et al. Diagnosis and management of microscopic colitis:current perspectives. Clin Exp Gastroenterol. 2014;7:273–284.
29. Stoicescu A, Becheanu G, Dumbrava M, et al. Microscopic colitis–a missed diagnosis in diarrhea-predominant irritable bowel syndrome. Maedica (Buchar). 2012;7:3–9.
30. Carmack S, Lash R, Gulizia J, et al. Lymphocytic disorders of the gastrointestinal tract:a review for the practicing pathologist. Adv Anat Pathol. 2009;16:290–306.
31. Pardi D, Ramnath V, Lofthus E, et al. Lymphocytic colitis:clinical features, treatment, and outcomes. Am J Gastroenterol. 2002;97:2829–2833.
32. Limsui D, Pardi DS, Camilleri M., Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis. 2007;13:175–181.
33. Faecal microbial transplantation in treatment of irritable bowel syndrome:a double blinded placebo controlled trial. University Hospital of North Norway; [Internet]. [cited 2016 Jun 7]. Available from:https://clinicaltrials.gov/ct2/show/NCT02154867?term=refit&rank=4.
34. Francis CY, Morris J, Whorwell PJ., The irritable bowel severity scoring system:a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11:395–402.
35. Geboes K, Riddel R, Öst A, et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut. 2000;47:404–409.
36. Oleson M, Eriksson S, Bohr J, et al. Microscopic colitis:a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993–1998. Gut. 2004;53:346–350.
37. Fernandez-Banares F, Salas A, Forne M, et al. Incidence of collagenous and lymphocytic colitis:a 5-year population-based study. Am J Gastroenterol. 1999;94:418–423.
38. Ozdil K, Sahin A, Calhan T, et al. The frequency of microscopic and focal active colitis in patients with irritable bowel syndrome. BMC Gastroenterol. 2011;11:96.
39. Tavakkoli H, Esmaeili FS, Emami MH, et al. Is microscopic colitis a missed diagnosis in diarrhoea-predominant irritable bowel syndrome? JRMS. 2008;13:202–206.
40. Bonderup OK, Wigh T, Nielsen GL, et al. The epidemiology of microscopic colitis:a 10-year pathology-based nationwide Danish cohort study. Scand J Gastroenterol. 2015;50:393–398.
41. Carpenter H, Termaine W, Batts K, et al. Sequential histologic evaluations in collagenous colitis:correlations with. Disease behaviour and sampling strategy. Dig Dis Sci 1992;37:1903–1909.